MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

20 May 2022 Evaluate
The total revenue for the quarter ended March 2022 remained nearly unchanged at Rs. 20193.00 millions.Net profit of the cmpany stood at Rs. 2469.00 millions for the quarter ended March 2022 a decline of -46.87% from Rs. 4647.00 millions  in the same quarter last year.The company reported a degrowth in operating Profit to 5113.00 millions from 5773.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 20193.00 20084.00 0.54 79819.00 77800.00 2.60 79819.00 77800.00 2.60
Other Income 537.00 -165.00 -425.45 1787.00 893.00 100.11 1787.00 893.00 100.11
PBIDT 5113.00 5773.00 -11.43 20968.00 23980.00 -12.56 20968.00 23980.00 -12.56
Interest 420.00 205.00 104.88 1349.00 709.00 90.27 1349.00 709.00 90.27
PBDT 4693.00 5568.00 -15.71 16426.00 21396.00 -23.23 16426.00 21396.00 -23.23
Depreciation 1228.00 1150.00 6.78 4787.00 4511.00 6.12 4787.00 4511.00 6.12
PBT 3465.00 4418.00 -21.57 11639.00 16885.00 -31.07 11639.00 16885.00 -31.07
TAX 996.00 -229.00 -534.93 3060.00 2123.00 44.14 3060.00 2123.00 44.14
Deferred Tax 217.00 -784.00 -127.68 458.00 -910.00 -150.33 458.00 -910.00 -150.33
PAT 2469.00 4647.00 -46.87 8579.00 14762.00 -41.88 8579.00 14762.00 -41.88
Equity 1024.00 1024.00 0.00 1024.00 1024.00 0.00 1024.00 1024.00 0.00
PBIDTM(%) 25.32 28.74 -11.91 26.27 30.82 -14.77 26.27 30.82 -14.77
Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..